Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
Recruiting
Observational Study
Mitral Regurgitation
Mitral Valve Disease
Mitral Valve Insufficiency
Mitral Valve Prolapse
Heart Valve Diseases
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- NeoChord · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Has Grade III Moderate or Grade IV Severe degenerative or mixed disease mitral valve regurgitation
* Study procedure completed after 31 December 2016
Exclusion Criteria:
* Heavily calcified valves
* Valvular retraction with severely reduced mobility
* Active bacterial endoca…
Contacts